Genetic stratification of neuroblastoma for treatment tailoring
- PMID: 21919696
- DOI: 10.2217/fon.11.87
Genetic stratification of neuroblastoma for treatment tailoring
Abstract
Neuroblastoma is the most common extracranial tumor of childhood. The clinical behavior is variable, ranging from spontaneous regression to fatal progression despite aggressive therapy. The most highly statistically significant and clinically relevant factors that are currently used for classification include stage, age, histopathologic category, MYCN oncogene status, chromosome 11q status and DNA ploidy. These genetic markers were analyzed separately by classical methods until recently: mainly fluorescence in situ hybridization or loss of heterozygosity. The development of genome-wide techniques such as comparative genomic hybridization, array comparative genomic hybridization and single nucleotide polymorphism allows the analysis of copy number variations through the whole genome in one step. This enabled the investigators to refine different genetic subtypes for the better comprehension of neuroblastoma tumor behavior and reach the conclusion that these data together with a genomic profile based on gene expression should be included in future treatment stratification.
Similar articles
-
Overall genomic pattern is a predictor of outcome in neuroblastoma.J Clin Oncol. 2009 Mar 1;27(7):1026-33. doi: 10.1200/JCO.2008.16.0630. Epub 2009 Jan 26. J Clin Oncol. 2009. PMID: 19171713
-
ArrayCGH-based classification of neuroblastoma into genomic subgroups.Genes Chromosomes Cancer. 2007 Dec;46(12):1098-108. doi: 10.1002/gcc.20496. Genes Chromosomes Cancer. 2007. PMID: 17823929
-
Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.BMC Cancer. 2007 May 25;7:89. doi: 10.1186/1471-2407-7-89. BMC Cancer. 2007. PMID: 17531100 Free PMC article. Review.
-
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.Cancer Res. 2006 Jun 15;66(12):6050-62. doi: 10.1158/0008-5472.CAN-05-4618. Cancer Res. 2006. PMID: 16778177
-
Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.Carcinogenesis. 2004 Sep;25(9):1599-609. doi: 10.1093/carcin/bgh173. Epub 2004 Apr 16. Carcinogenesis. 2004. PMID: 15090470 Review.
Cited by
-
MicroRNA-186-5p represses neuroblastoma cell growth via downregulation of Eg5.Am J Transl Res. 2019 Apr 15;11(4):2245-2256. eCollection 2019. Am J Transl Res. 2019. PMID: 31105832 Free PMC article.
-
Telomere Maintenance Mechanisms in Cancer.Genes (Basel). 2018 May 3;9(5):241. doi: 10.3390/genes9050241. Genes (Basel). 2018. PMID: 29751586 Free PMC article. Review.
-
Research progress of neuroblastoma related gene variations.Oncotarget. 2017 Mar 14;8(11):18444-18455. doi: 10.18632/oncotarget.14408. Oncotarget. 2017. PMID: 28055978 Free PMC article. Review.
-
Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.BMC Med Genet. 2012 Sep 17;13:83. doi: 10.1186/1471-2350-13-83. BMC Med Genet. 2012. PMID: 22984959 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical